Overview

Azithromycin for Meibomian Gland Disease

Status:
Recruiting

Trial end date:
2023-12-01

Target enrollment:

Participant gender:

Summary

This study aims to elucidate the effectiveness of oral azithromycin in treating symptomatic dry eye syndrome secondary to Meibomian gland dysfunction.

Phase:

Phase 4

Details

Lead Sponsor:

University of California, San Francisco

Treatments:

Azithromycin